The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical (and solvable) issue is finding, ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

When REDCap did not offer a way to use covariate-adaptive randomization algorithms (CARAs), researchers realized they would ...

Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

The development of new medications is a long, complex, and costly process. Productivity—how efficiently a drug developer creates value from their investment—is key to success, yet it often remains ...

Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's disease across the US and worldwide. This collaboration involves a clinical ...

AI has been making headlines in the last year for its potential use in logistics, business, technology, healthcare, and more. But what about clinical research? We expect sponsors and clinical ...